180 Wealth Advisors LLC Invests $34,000 in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX)

180 Wealth Advisors LLC bought a new stake in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 13,000 shares of the company’s stock, valued at approximately $34,000.

Wall Street Analyst Weigh In

Separately, Raymond James raised shares of Eupraxia Pharmaceuticals to a “strong-buy” rating in a report on Wednesday, May 22nd.

Eupraxia Pharmaceuticals Price Performance

Shares of EPRX traded down $0.01 during mid-day trading on Thursday, hitting $2.60. 4,742 shares of the company traded hands, compared to its average volume of 18,327. The stock has a market capitalization of $70.93 million and a PE ratio of -2.61. The business has a 50-day simple moving average of $2.63. Eupraxia Pharmaceuticals Inc. has a one year low of $2.39 and a one year high of $5.75.

Eupraxia Pharmaceuticals Profile

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company’s lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee.